Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 353

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

An international cohort study of cancer in systemic lupus erythematosus

Bernatsky, S., Boivin, J. F., Joseph, L., Rajan, R., Zoma, A., Manzi, S., Ginzler, E., Urowitz, M., Gladman, D., Fortin, P. R., Petri, M., Edworthy, S., Barr, S., Gordon, C., Bae, S. C., Sibley, J., Isenberg, D., Rahman, A., Aranow, C., Dooley, M. A., Steinsson, K., Nived, O., Sturfelt, G., Alarcón, G., Senécal, J. L., Zummer, M., Hanly, J., Ensworth, S., Pope, J., El‐Gabalawy, H., McCarthy, T., St. Pierre, Y., Ramsey‐Goldman, R., Clarke, A.·2005·Arthritis & Rheumatism

Abstract

Objective: There is increasing evidence in support of an association between systemic lupus erythematosus (SLE) and malignancy, but in earlier studies the association could not be quantified precisely. The present study was undertaken to ascertain the incidence of cancer in SLE patients, compared with that in the general population. Methods: We assembled a multisite (23 centers) international cohort of patients diagnosed as having SLE. Patients at each center were linked to regional tumor registries to determine cancer occurrence. Standardized incidence ratios (SIRs) were calculated as the ratio of observed to expected cancers. Cancers expected were determined by multiplying person‐years in the cohort by the geographically matched age, sex, and calendar year–specific cancer rates, and summing over all person‐years. Results: The 9,547 patients from 23 centers were observed for a total of 76,948 patient‐years, with an average followup of 8 years. Within the observation interval, 431 cancers occurred. The data confirmed an increased risk of cancer among patients with SLE. For all cancers combined, the SIR estimate was 1.15 (95% confidence interval [95% CI] 1.05–1.27), for all hematologic malignancies, it was 2.75 (95% CI 2.13–3.49), and for non‐Hodgkin's lymphoma, it was 3.64 (95% CI 2.63–4.93). The data also suggested an increased risk of lung cancer (SIR 1.37; 95% CI 1.05–1.76), and hepatobiliary cancer (SIR 2.60; 95% CI 1.25, 4.78). Conclusion: These results support the notion of an association between SLE and cancer and more precisely define the risk of non‐Hodgkin's lymphoma in SLE. It is not yet known whether this association is mediated by genetic factors or exogenous exposures.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.21029

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 353

Metadata

Authors
Bernatsky, S., Boivin, J. F., Joseph, L., Rajan, R., Zoma, A., Manzi, S., Ginzler, E., Urowitz, M., Gladman, D., Fortin, P. R., Petri, M., Edworthy, S., Barr, S., Gordon, C., Bae, S. C., Sibley, J., Isenberg, D., Rahman, A., Aranow, C., Dooley, M. A., Steinsson, K., Nived, O., Sturfelt, G., Alarcón, G., Senécal, J. L., Zummer, M., Hanly, J., Ensworth, S., Pope, J., El‐Gabalawy, H., McCarthy, T., St. Pierre, Y., Ramsey‐Goldman, R., & Clarke, A.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2005-05
Volume
52
Issue
5
Pages
1481-1490
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2039556556
Cited by
353
References
1
FWCI
12.39
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An international cohort study of cancer in systemic lupus erythematosus. https://app.cochat.ai/papers/10.1002/art.21029
The paper
Bernatsky, S., Boivin, J. F., Joseph, L., Rajan, R., Zoma, A., Manzi, S., Ginzler, E., Urowitz, M., Gladman, D., Fortin, P. R., Petri, M., Edworthy, S., Barr, S., Gordon, C., Bae, S. C., Sibley, J., Isenberg, D., Rahman, A., Aranow, C., . . . Clarke, A. (2005). An international cohort study of cancer in systemic lupus erythematosus. Arthritis & Rheumatism. https://doi.org/10.1002/art.21029

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.